enCore Energy: Lusochimica's STEP Seal Marks Sustainable Innovation in Pharma Production
- Lusochimica S.p.A. receives the STEP Seal for its commitment to sustainable pharmaceutical production through the SmartNEBI project.
- The SmartNEBI project utilizes biocatalysis and flow chemistry to reduce energy consumption and environmental impact in drug synthesis.
- Lusochimica's recognition showcases its leadership in sustainable practices, setting a precedent for innovation in the pharmaceutical industry.
Lusochimica's STEP Seal: A Leap Toward Sustainable Pharmaceutical Production
Lusochimica S.p.A., a member of the Menarini Group, achieves a significant milestone by being awarded the STEP Seal by the European Commission on September 22, 2025. This honor highlights the company's commitment to innovation and sustainability within the pharmaceutical industry, particularly through its SmartNEBI project. Focused on the sustainable synthesis of nebivolol, a vital active pharmaceutical ingredient (API) for cardiovascular treatments, the initiative has garnered recognition not just for its innovative approach but for its alignment with the EU's strategic health goals.
The SmartNEBI project is part of the EU4Health program, which aims to tackle health challenges across Europe through innovative projects. Managed by HaDEA, the project showcases Lusochimica's ability to integrate cutting-edge technologies such as biocatalysis and flow chemistry. These methods promise to enhance efficiency and selectivity in chemical transformations, ultimately leading to a more environmentally friendly production process. By minimizing energy consumption and solvent usage, SmartNEBI demonstrates a commitment to reducing the environmental footprint of pharmaceutical manufacturing, positioning Lusochimica as a leader in sustainable practices within the industry.
Roberto Falorni, General Manager of Lusochimica, articulates the pride felt by the Menarini Group in receiving the STEP Seal. He emphasizes that this recognition not only signifies a technological advancement but also reflects a broader commitment to greener, safer pharmaceutical production. By optimizing energy use and adopting sustainable methods, Lusochimica sets a precedent for the pharmaceutical sector, demonstrating how innovation can align with environmental stewardship and public health objectives.
In addition to its recognition, the SmartNEBI project underscores the importance of collaboration in the pharmaceutical industry. By working under the auspices of European funding programs, Lusochimica not only reinforces its own capabilities but also contributes to a collective effort to advance health technologies across Europe. This initiative serves as a model for other companies seeking to innovate sustainably.
As the pharmaceutical industry faces increasing pressure to reduce its environmental impact, Lusochimica's SmartNEBI project stands out as a beacon of progress. The STEP Seal serves as a testament to the company's dedication to integrating sustainable practices into its operational framework, thus paving the way for a greener future in pharmaceutical manufacturing.
